Lipidomics links oxidized phosphatidylcholines and coronary arteritis in Kawasaki disease
Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2019. For permissions, please email: journals.permissionsoup.com..
AIMS: Coronary arteritis is a life-threatening complication that may arise in the acute stage of Kawasaki disease (KD), the leading cause of systemic vasculitis in childhood. Various microorganisms and molecular pathogens have been reported to cause KD. However, little is known about the key molecules that contribute to the development of coronary arteritis in KD.
METHODS AND RESULTS: To identify causative molecules for coronary arteritis in KD, we prospectively recruited 105 patients with KD and 65 disease controls in four different parts of Japan from 2015 to 2018. During this period, we conducted lipidomics analyses of their sera using liquid chromatography-mass spectrometry (LC-MS). The comprehensive LC-MS system detected a total of 27 776 molecules harbouring the unique retention time and m/z values. In the first cohort of 57 KD patients, we found that a fraction of these molecules showed enrichment patterns that varied with the sampling region and season. Among them, 28 molecules were recurrently identified in KD patients but not in controls. The second and third cohorts of 48 more patients with KD revealed that these molecules were correlated with inflammatory markers (leucocyte counts and C-reactive proteins) in the acute stage. Notably, two of these molecules (m/z values: 822.55 and 834.59) were significantly associated with the development of coronary arteritis in the acute stage of KD. Their fragmentation patterns in the tandem MS/MS analysis were consistent with those of oxidized phosphatidylcholines (PCs). Further LC-MS/MS analysis supported the concept that reactive oxygen species caused the non-selective oxidization of PCs in KD patients. In addition, the concentrations of LOX-1 ligand containing apolipoprotein B in the plasma of KD patients were significantly higher than in controls.
CONCLUSION: These data suggest that inflammatory signals activated by oxidized phospholipids are involved in the pathogenesis of coronary arteritis in KD. Because the present study recruited only Japanese patients, further examinations are required to determine whether oxidized PCs might be useful biomarkers for the development of coronary arteritis in broad populations of KD.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:117 |
|---|---|
| Enthalten in: |
Cardiovascular research - 117(2021), 1 vom: 01. Jan., Seite 96-108 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Nakashima, Yasutaka [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 06.10.2021 Date Revised 06.10.2021 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1093/cvr/cvz305 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM303849347 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM303849347 | ||
| 003 | DE-627 | ||
| 005 | 20231225113712.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/cvr/cvz305 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1012.xml |
| 035 | |a (DE-627)NLM303849347 | ||
| 035 | |a (NLM)31782770 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Nakashima, Yasutaka |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Lipidomics links oxidized phosphatidylcholines and coronary arteritis in Kawasaki disease |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 06.10.2021 | ||
| 500 | |a Date Revised 06.10.2021 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2019. For permissions, please email: journals.permissionsoup.com. | ||
| 520 | |a AIMS: Coronary arteritis is a life-threatening complication that may arise in the acute stage of Kawasaki disease (KD), the leading cause of systemic vasculitis in childhood. Various microorganisms and molecular pathogens have been reported to cause KD. However, little is known about the key molecules that contribute to the development of coronary arteritis in KD | ||
| 520 | |a METHODS AND RESULTS: To identify causative molecules for coronary arteritis in KD, we prospectively recruited 105 patients with KD and 65 disease controls in four different parts of Japan from 2015 to 2018. During this period, we conducted lipidomics analyses of their sera using liquid chromatography-mass spectrometry (LC-MS). The comprehensive LC-MS system detected a total of 27 776 molecules harbouring the unique retention time and m/z values. In the first cohort of 57 KD patients, we found that a fraction of these molecules showed enrichment patterns that varied with the sampling region and season. Among them, 28 molecules were recurrently identified in KD patients but not in controls. The second and third cohorts of 48 more patients with KD revealed that these molecules were correlated with inflammatory markers (leucocyte counts and C-reactive proteins) in the acute stage. Notably, two of these molecules (m/z values: 822.55 and 834.59) were significantly associated with the development of coronary arteritis in the acute stage of KD. Their fragmentation patterns in the tandem MS/MS analysis were consistent with those of oxidized phosphatidylcholines (PCs). Further LC-MS/MS analysis supported the concept that reactive oxygen species caused the non-selective oxidization of PCs in KD patients. In addition, the concentrations of LOX-1 ligand containing apolipoprotein B in the plasma of KD patients were significantly higher than in controls | ||
| 520 | |a CONCLUSION: These data suggest that inflammatory signals activated by oxidized phospholipids are involved in the pathogenesis of coronary arteritis in KD. Because the present study recruited only Japanese patients, further examinations are required to determine whether oxidized PCs might be useful biomarkers for the development of coronary arteritis in broad populations of KD | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Multicenter Study | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Atherogenic signals | |
| 650 | 4 | |a Coronary artery lesions | |
| 650 | 4 | |a Kawasaki disease | |
| 650 | 4 | |a Lipidomics | |
| 650 | 4 | |a Mass spectrometry | |
| 650 | 4 | |a Oxidized phosphatidylcholines | |
| 650 | 7 | |a Adaptor Proteins, Signal Transducing |2 NLM | |
| 650 | 7 | |a Biomarkers |2 NLM | |
| 650 | 7 | |a LAT2 protein, human |2 NLM | |
| 650 | 7 | |a Lipoproteins, LDL |2 NLM | |
| 650 | 7 | |a OLR1 protein, human |2 NLM | |
| 650 | 7 | |a Phosphatidylcholines |2 NLM | |
| 650 | 7 | |a Scavenger Receptors, Class E |2 NLM | |
| 650 | 7 | |a Phenylalanine |2 NLM | |
| 650 | 7 | |a 47E5O17Y3R |2 NLM | |
| 700 | 1 | |a Sakai, Yasunari |e verfasserin |4 aut | |
| 700 | 1 | |a Mizuno, Yumi |e verfasserin |4 aut | |
| 700 | 1 | |a Furuno, Kenji |e verfasserin |4 aut | |
| 700 | 1 | |a Hirono, Keiichi |e verfasserin |4 aut | |
| 700 | 1 | |a Takatsuki, Shinichi |e verfasserin |4 aut | |
| 700 | 1 | |a Suzuki, Hiroyuki |e verfasserin |4 aut | |
| 700 | 1 | |a Onouchi, Yoshihiro |e verfasserin |4 aut | |
| 700 | 1 | |a Kobayashi, Tohru |e verfasserin |4 aut | |
| 700 | 1 | |a Tanabe, Kazuhiro |e verfasserin |4 aut | |
| 700 | 1 | |a Hamase, Kenji |e verfasserin |4 aut | |
| 700 | 1 | |a Miyamoto, Tomofumi |e verfasserin |4 aut | |
| 700 | 1 | |a Aoyagi, Ryohei |e verfasserin |4 aut | |
| 700 | 1 | |a Arita, Makoto |e verfasserin |4 aut | |
| 700 | 1 | |a Yamamura, Kenichiro |e verfasserin |4 aut | |
| 700 | 1 | |a Tanaka, Tamami |e verfasserin |4 aut | |
| 700 | 1 | |a Nishio, Hisanori |e verfasserin |4 aut | |
| 700 | 1 | |a Takada, Hidetoshi |e verfasserin |4 aut | |
| 700 | 1 | |a Ohga, Shouichi |e verfasserin |4 aut | |
| 700 | 1 | |a Hara, Toshiro |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cardiovascular research |d 1967 |g 117(2021), 1 vom: 01. Jan., Seite 96-108 |w (DE-627)NLM000080209 |x 1755-3245 |7 nnns |
| 773 | 1 | 8 | |g volume:117 |g year:2021 |g number:1 |g day:01 |g month:01 |g pages:96-108 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1093/cvr/cvz305 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 117 |j 2021 |e 1 |b 01 |c 01 |h 96-108 | ||